Comparing the Efficacy and Safety of TQB2440 Versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 TrialQingyuan Zhang,Shusen Wang,Nanlin Li,Qiao Cheng,Yu Ren,Xuchen Cao,Jianjun Huang,Caigang Liu, Hongwei Yang,Limin Wei,Zhangjun Song,Huadong Zhao,Fangling Ning,Xiaojia Wang,Dehong Zou,Xiaohua Zeng, Jie Hao,Yunjiang Liu, Huijuan Wang,Nie Jianyun,Liang Li, Lina Liu,Tao Sun, Xiaobo Hu,Zhenhua Zhai,Huihua Xiong,Yuanqi Zhang,Enxiang Zhou, Jing Sun,Zhenhai Cai, Antai Zhang,Shui Wang, Junyang Mo, Qun Su, Xiuheng Qi,Guoren Zhou,Shuqun Zhang,Guozhong Cui,Wei Wang,Mingjiang Fan,Xinyu Qian,Xinhong Wu,Zhihong Wang,Jiuda Zhao,Yonghui Luo, Yanming Zhang,Fuguo Tian, Jiye Zhang, Dongning Chai,Qingshan LiCANCER RESEARCH（2024）引用 0|浏览8AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
